this CEO should be in jail, not to allow to run another bioscam... if the study was not effective, why did she sign MFG contract to expand mfg capability?
any delay would encourage shorts to drive it below $10/sh.. sooner is better for any announcement .. stop bleeding is the most important at the moment.. GL longs
WS is a corrupted institution, hedgies and corrupted traders triggered the effect by naked shorting a stock to create fear to retail investors. Eventually, some investors will give up their shares before the good news is released.. unless bad news is leaked by insiders.. 16% drop before the news is unusual.. GL
effe, appreciate your enthusiasm about the technical, but upcoming news is the binary event.. all the technical and the current trends are meaningless..
if data is marginal or no good, I think many lawsuits will be followed due to many "bait 'n switch" actions by the CLDN leaderships like MFG's agreement, secondary announcement, CEO promising "exciting data" and the recent CEO's stock selling which signalling the checkpoint data is better than expectations.
I'm hopeful that P2 data is similar or better than P1 data, and get fast track approval by the FDA to make this drug available to the market ASAP... It is a difficult problem to solve, so it could go either way at this stage.. GL longs..
here's my thoughts about your 2000 buy premarket orders didn't get filled.
1. Do you have enough $ in your cash account ?
2. Did you place as AON or limit order in pre-market?
3. Have you ever get your orders filled during the normal trading hours ?
4. Many brokerages do not allow limit or AON orders in pre-market.
5. You can easily call them up and ask for an explanation, instead of asking question in the YMB.
if all the shorts are leaning on one side of the boat, I would bet that the boat will capsize soon.. Short some more so you can cover at higher prices later... GL
Sentiment: Strong Buy
I think CEO mentioned Cupid 3 as a precautionary (the worse case), so she won't get sued for misleading investors (layout all the possible scenarios, just in case FDA wants to see larger sample size to validate the previous studies)..
looks like they're preparing to ramp up production with MFG agreement ( why waste time/resources if data is marginal or STATISTICAL IN-SIGNIFICANT ). GL longs..
rfw, well said.. I like the way you laid out the probability of the good news which is expected by the activities led to this point ..the major obstacle is the checkpoint is statistical significant and P value is less than .005.. I am hopeful this is the case.. GL